KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Non-cash Items (2017 - 2018)

Teva Pharmaceutical Industries' Non-cash Items history spans 8 years, with the latest figure at $2.4 million for Q4 2018.

  • For the quarter ending Q4 2018, Non-cash Items fell 67.57% year-over-year to $2.4 million, compared with a TTM value of $2.4 million through Dec 2018, down 67.57%, and an annual FY2018 reading of $2.4 million, down 67.57% over the prior year.
  • Non-cash Items for Q4 2018 was $2.4 million at Teva Pharmaceutical Industries, down from $7.4 million in the prior quarter.
  • The five-year high for Non-cash Items was $312.2 million in Q4 2014, with the low at $2.4 million in Q4 2018.
  • Average Non-cash Items over 4 years is $83.3 million, with a median of $9.3 million recorded in 2015.
  • Year-over-year, Non-cash Items surged 3483.02% in 2014 and then tumbled 96.38% in 2015.
  • Tracing TEVA's Non-cash Items over 4 years: stood at $312.2 million in 2014, then tumbled by 96.38% to $11.3 million in 2015, then tumbled by 34.51% to $7.4 million in 2017, then tumbled by 67.57% to $2.4 million in 2018.
  • Per Business Quant, the three most recent readings for TEVA's Non-cash Items are $2.4 million (Q4 2018), $7.4 million (Q4 2017), and $11.3 million (Q4 2015).